In this article, we will discuss: 11 Best Marijuana Stocks to Buy Right Now.
On March 23, 2026, Cannabis Business Times reported that bipartisan lawmakers introduced the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act, which aims to provide financial access for cannabis enterprises in the United States. Representatives Troy Carter and Guy Reschenthaler sponsored the bill, which plans to allow state-approved operators to list on major US exchanges and acquire traditional banking services. Carter stated that “access to capital remains one of the biggest barriers,” stressing funding restrictions throughout the sector. The proposal would also provide safe harbor protections to financial institutions that offer loans, insurance, and investment services.
The law operates federal prohibition-related constraints that hinder U.S. operators compared with Canadian peers. Saphira Galoob, CEO of the US Cannabis Roundtable, stated that the law ensures equal chances for American cannabis entrepreneurs, while Boris Jordan described it as a “common-sense step” towards regulatory consistency. The measure also protects financial institutions that provide funds and services. Meanwhile, cannabis is still classified as a Schedule I substance, and President Donald Trump has ordered a prospective reclassification assessment, but no firm timeline has been provided.
With that said, here are the 11 Best Marijuana Stocks to Buy Right Now.
kostrez/Shutterstock.com
Methodology:
We used screeners to identify Best Marijuana Stocks and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds. Finally, we ranked these stocks in ascending order based on the number of hedge fund holders.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
11. Advanced Flower Capital Inc. (NASDAQ:AFCG)
Number of Hedge Fund Holders: 5
On March 4, 2026, Advanced Flower Capital Inc. (NASDAQ:AFCG) reported fourth-quarter 2025 GAAP net income of $0.9 million, or $0.04 per share, with distributable earnings of $(2.8) million, or ($0.12) per share. The corporation announced a full-year GAAP net loss of $(20.7) million, or $0.95 per share, while producing distributable earnings of $8.7 million, or $0.39 per share.
Advanced Flower Capital Inc. (NASDAQ:AFCG)’s CEO, Dan Neville, stated that the company focused on disciplined portfolio management and completed its BDC conversion in 2025 by resolving underperforming loans and reallocating capital to lower-middle-market enterprises. On March 2, 2026, the firm declared a cash dividend of $0.05 per common share for the first quarter of 2026, which will be paid on April 15, 2026, to shareholders of record as of March 31, 2026.
Advanced Flower Capital Inc. (NASDAQ:AFCG) offers commercial real estate finance services. Its primary business is to originate, structure, underwrite, and manage senior secured loans and other types of loans for established businesses in the cannabis market across states.
10. Organigram Global Inc. (NASDAQ:OGI)
Number of Hedge Fund Holders: 7
On March 5, 2026, Organigram Global Inc. (NASDAQ:OGI) reported the debut of SHRED Shotz, a 65ml single-serve cannabis beverage powered by its FAST nanoemulsion platform with a 15-minute onset. The corporation claims that SHRED generated more than $200 million in retail sales in 2025 and that the new product expands the brand into smaller serving sizes to reach new customers. Vice President Eric Williams stated that the launch incorporates user insights into product innovation while utilizing FAST technology for simplicity and predictability.
Organigram Global Inc. (NASDAQ:OGI) announced first-quarter fiscal 2026 gross revenue of $97.3 million and net revenue of $63.5 million, up 46% and 49% year-over-year, respectively, while producing adjusted EBITDA of $5.3 million, a 273% growth. According to CEO James Yamanaka, the corporation retained Canadian market leadership while improving efficiency, resulting in increased profitability through foreign expansion and operational discipline.
Organigram Global Inc. (NASDAQ:OGI) provides high-quality, indoor-grown cannabis to patients and adult recreational consumers, as well as develops international commercial alliances to expand the company’s global footprint.
